Hormone | Treatment | n | 0 | 1 | 1.5 | 2 | 2.5 | Average |
---|
Vehicle | Saline | 6 | 6 | | | | | 0.0 |
DOX | 7 | | | 4 | 1 | 2 | 1.9 |
E2 | Saline | 7 | 7 | | | | | 0.0 |
DOX | 7 | | 3 | 2 | 2 | | 1.4 |
E2 + P4 | Saline | 7 | 7 | | | | | 0.0 |
DOX | 7 | 1 | 2 | 3 | 1 | | 1.2 |
E2 + Tam | Saline | 7 | 7 | | | | | 0.0 |
DOX | 7 | | | 4 | 2 | 1 | 1.8 |
Tam | Saline | 7 | 7 | | | | | 0.0 |
DOX | 7 | | | 3 | 1 | 3 | 2.0 |
P4 | Saline | 7 | 7 | | | | | 0.0 |
DOX | 7 | 1 | 1 | 4 | 1 | | 1.3 |
- Histopathology of cardiac sections from the ovariectomized SHRs at day 12 was assessed for cardiomyocyte lesions (myofibrillar loss and vacuolization) by a board-certified pathologist. The cardiomyopathy or lesion score indicates the percentage of affected cardiomyocytes within the sampled heart section: 0 is no observed change, 1 is < 5%, 1.5 is 5–15%, 2 is 16–25%, 2.5 is 26–35%, and 3 is > 35%